NCT00151450已完成3 期
An 8-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Study Of Pregabalin (300-600 Mg/Day) And Venlafaxine XR (75-225 Mg/Day) For The Acute Treatment Of DSM-IV Generalized Anxiety Disorder In Outpatients
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.46 个研究点 分布在 8 个国家目标入组 390 人开始时间: 2005年3月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 390
- 试验地点
- 46
- 主要终点
- Evaluation of the efficacy of pregabalin and Venlafaxine XR in the treatment of generalized anxiety disorder.
研究概览
简要总结
The purpose of the study is to compare pregabalin to Venlafaxine XR and placebo in the treatment of generalized anxiety disorder.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male and female outpatients with diagnosis of generalized anxiety disorder.
排除标准
- •Any serious or uncontrolled medical condition.
- •Current diagnosis of depression, dysthymia, obsessive-compulsive disorder.
结局指标
主要结局
Evaluation of the efficacy of pregabalin and Venlafaxine XR in the treatment of generalized anxiety disorder.
次要结局
未报告次要终点
研究者
研究点 (46)
Loading locations...
相似试验
已完成
3 期
A Study of the Efficacy and Safety of Pregabalin for the Treatment of FibromyalgiaFibromyalgiaNCT00645398Pfizer's Upjohn has merged with Mylan to form Viatris Inc.751
已完成
3 期
A Study For Pregabalin In Patients With FibromyalgiaFibromyalgiaNCT01387607Pfizer's Upjohn has merged with Mylan to form Viatris Inc.343
已完成
4 期
Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious PatientsAnxiety DisordersDepressionNCT00546923Wyeth is now a wholly owned subsidiary of Pfizer210
已完成
3 期
Randomized, Double-Blind, Placebo-Controlled Study Of Pregabalin In Patients With FibromyalgiaFibromyalgiaNCT00830167Pfizer's Upjohn has merged with Mylan to form Viatris Inc.498
已完成
3 期
Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).Generalized Anxiety DisorderNCT00413010Pfizer's Upjohn has merged with Mylan to form Viatris Inc.356